Pharmafile Logo

long-term condition

- PMLiVE

FDA approves Biogen Idec’s haemophilia drug

Eloctate now available to help control and prevent bleeding episodes

- PMLiVE

EMA adaptive licensing project gathers pace

Regulator picks two drugs to pilot early access scheme

- PMLiVE

Former Merck & Co exec to lead Seres

Roger Pomerantz was senior VP at pharma giant

Pharma deals during May 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for May 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Pradaxa cleared for new indications in Europe

Boehringer drug set for use in deep vein thrombosis and pulmonary embolism

- PMLiVE

GSK takes anti-inflammatory drug into phase III as heart therapy

Studies losmapimod’s potential in acute coronary syndrome

- PMLiVE

Halozyme to resume pancreatic cancer study

FDA says PEGPH20 trial can continue

- PMLiVE

New president at Bayer Healthcare

Dieter Weinand replaces departing Andreas Fibig

- PMLiVE

Otsuka launches European ADPKD forum

Aims to lead awareness raising plans for rare genetic condition

Lucid expands with new London office

UK med ed agency opens doors in Hammersmith

- PMLiVE

AFFiRiS claims a first in Alzheimer’s disease therapy

Says AD04 is first drug to demonstrate disease modification

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links